| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Royal Ottawa Health Care Group is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The F. Dohmen Co. is a fifth-generation, family-owned business, which has been serving the healthcare industry for over 145 years.
Ascendian Healthcare Consulting is a Roseville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Contec Vision is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.